抗体
试剂盒
多肽
蛋白
组织芯片
产品中心
Product Center
| 货号 | 名称 | 纯度 | CAS号 | 分子式 | 分子量 |
| TD-AP223223 | 靶向肽CSK、CSKSSDYQC (Disulfide bridge: C1-C9) | C₃₉H₆₁N₁₁O₁₇S₂ | 1020.1 | ||
| TD-AP204901 | 心脏靶向肽CTP | 1052692-86-0 | C₆₄H₉₃N₁₉O₁₉ | 1432.54 | |
| TD-AP504101 | EDB-FN靶向肽：ZD2 | 95% 或98%可选 | C₃₅H₆₀N₁₂O₁₅S₂ | 953.05 | |
| TD-AP134478 | 依多曲肽、Edotreotide | 204318-14-9 | C₆₅H₉₂N₁₄O₁₈S₂ | 1421.64 | |
| TD-AP499035 | α/β Integrin靶向肽：EETI 2.5F | 95% 或98%可选 | C₁₃₄H₂₁₃N₄₃O₄₅S₆ | 3338.78 | |
| TD-AP466179 | 脑靶向多肽：FITC-Angiopep-2 | 95% 或98%可选 | C₁₃₁H₁₇₁N₃₁O₃₇S₁ | 2804.01 | |
| TD-AP439594 | 靶向肽：FRα-targeting peptide C7 | 95% 或98%可选 | 2159055-74-8 | C₆₂H₉₀N₁₈O₁₆S₁ | 1375.55 |
| TD-AP144109 | G3-C12 | C₇₄H₁₁₅N₂₃O₂₃S₂ | 1758.98 | ||
| TD-AP190913 | 甘丙肽Galanin(1-13)-SpantideI | 95%、98% | 143868-20-6 | C₁₃₈H₁₉₉N₃₅O₃₀ | 2828.27 |
| TD-AP568423 | 胃泌素释放肽受体 (GRPR）靶向肽：GB-6 | 95% 或98%可选 | 2413262-74-3 | C₃₂H₄₅N₁₁O₈ | 711.77 |
| TD-AP458318 | 脑胶质瘤靶向肽：GL1 | 95% 或98%可选 | C₆₅H₉₈N₂₀O₁₈ | 1447.6 | |
| TD-AP115150 | M细胞靶向肽GRGDS | 95%、98% | 96426-21-0/2828433-23-2 | C₁₇H₃₀N₈O₉ | 490.47 |
| TD-AP424153 | 靶向肽GX1、CGNSNPKSC (Disulfide bridge: C1-C9) | C₃₃H₅₆N₁₂O₁₄S₂ | 909 | ||
| TD-AP530457 | 造血干细胞靶向肽：SP-7 | 95% 或98%可选 | C₃₄H₅₄N₈O₁₂ | 766.84 | |
| TD-AP429694 | 靶向肽HN-1 | C₅₇H₉₆N₁₈O₁₈ | 1321.48 | ||
| TD-AP128437 | RGD环肽：iRGD peptide、c(CRGDKGPDC) | 1392278-76-0 | C₃₅H₅₇N₁₃O₁₄S₂ | 948.04 | |
| TD-AP459131 | CD40靶向肽：KGYY15 | 95% 或98%可选 | 1690215-31-6 | C₈₄H₁₂₉N₂₁O₂₂S₁ | 1817.12 |
| TD-AP181272 | 线粒体靶向肽、抗菌肽：(KLAKLAK)2 | 95%、98% | 184240-26-4 | C₇₂H₁₃₈N₂₀O₁₅ | 1523.99 |
| TD-AP514908 | Cu(2+) 离子亲和肽：LI-18 | 95% 或98%可选 | 222557-92-8 | C₉₄H₁₆₀N₃₂O₂₂ | 2090.48 |
| TD-AP208736 | p32靶向肽：Lin TT1 | C₃₆H₆₈N₁₆O₁₂ | 917.03 |